How to buy AgeX Therapeutics shares | 05 March price $2.08

How to buy AgeX Therapeutics shares | $2.08

Own AgeX Therapeutics shares in just a few minutes. Share price changes are updated daily.

Posted

Fact checked

AgeX Therapeutics, Inc (AGE) is a leading biotechnology business based in the US. It opened the day at $2.2 after a previous close of $2.23. During the day the price has varied from a low of $2.08 to a high of $2.2369. The latest price was $2.08 (25 minute delay). AgeX Therapeutics is listed on the NYSE MKT and employs 17 staff. All prices are listed in US Dollars.

How to buy shares in AgeX Therapeutics

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: AGE in this case.
  5. Research AgeX Therapeutics shares. The platform should provide the latest information available.
  6. Buy your AgeX Therapeutics shares. It's that simple.
The whole process can take as little as 15 minutes.

AgeX Therapeutics share price

Use our graph to track the performance of AGE stocks over time.

AgeX Therapeutics shares at a glance

Information last updated 2021-03-05.
Open$2.2
High$2.2369
Low$2.08
Close$2.08
Previous close$2.23
Change $-0.15
Change % -6.7265%
Volume 239,836
Information last updated 2021-03-03.
52-week range$0.666 - $3.06
50-day moving average $2.1003
200-day moving average $1.577
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.318
Promoted
eToro Free Stocks

Invest in AgeX Therapeutics shares with 0% commission

Other fees may apply. Your capital is at risk.

  • Unlimited trades, with no dealing charges or management fees
  • If your trades get copied you can earn extra money
  • Create an account today in a few minutes

Fees for buying 100x AgeX Therapeutics shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
Fineco logo £0 No minimum £4.39
£154.94 total
Capital at risk
eToro Free Stocks logo £0 $500 £0.75
£151.30 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £0.87
£151.42 total
Capital at risk
Stake logo £0 £50 £1.04
£151.59 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £13.75
£164.30 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £10.54
£161.09 total
Capital at risk
Halifax Share Dealing Account logo £0 £20 £14.67
£165.22 total
Capital at risk

Full comparison of share dealing platforms

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is it a good time to buy AgeX Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

AgeX Therapeutics price performance over time

Historical closes compared with the last close of $2.08

1 week (2021-02-25) -0.72%
1 month (2021-02-05) -0.95%
3 months (2020-12-04) 22.35%
6 months (2020-09-04) 160.33%
1 year (2020-03-04) 84.07%
2 years (2019-03-04) -49.88%

AgeX Therapeutics financials

Revenue TTM $1.9 million
Gross profit TTM $1.5 million
Return on assets TTM -110.41%
Return on equity TTM -1881.2%
Profit margin 0%
Book value $0.115
Market capitalisation $95 million

TTM: trailing 12 months

How to short and sell AgeX Therapeutics shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "AGE.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 407,255 AgeX Therapeutics shares held short by investors – that's known as AgeX Therapeutics's "short interest". This figure is 12% up from 363,471 last month.

There are a few different ways that this level of interest in shorting AgeX Therapeutics shares can be evaluated.

AgeX Therapeutics's "short interest ratio" (SIR)

AgeX Therapeutics's "short interest ratio" (SIR) is the quantity of AgeX Therapeutics shares currently shorted divided by the average quantity of AgeX Therapeutics shares traded daily (recently around 490668.6746988). AgeX Therapeutics's SIR currently stands at 0.83. In other words for every 100,000 AgeX Therapeutics shares traded daily on the market, roughly 830 shares are currently held short.

However AgeX Therapeutics's short interest can also be evaluated against the total number of AgeX Therapeutics shares, or, against the total number of tradable AgeX Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AgeX Therapeutics's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 AgeX Therapeutics shares in existence, roughly 10 shares are currently held short) or 0.0192% of the tradable shares (for every 100,000 tradable AgeX Therapeutics shares, roughly 19 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against AgeX Therapeutics.

Find out more about how you can short AgeX Therapeutics stock.

AgeX Therapeutics share dividends

We're not expecting AgeX Therapeutics to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Have AgeX Therapeutics's shares ever split?

AgeX Therapeutics's shares were split on a 15:16 basis on 6 May 2015. So if you had owned 16 shares the day before before the split, the next day you'd have owned 15 shares. This wouldn't directly have changed the overall worth of your AgeX Therapeutics shares – just the quantity. However, indirectly, the new 6.7% higher share price could have impacted the market appetite for AgeX Therapeutics shares which in turn could have impacted AgeX Therapeutics's share price.

AgeX Therapeutics share price volatility

Over the last 12 months, AgeX Therapeutics's shares have ranged in value from as little as $0.666 up to $3.06. A popular way to gauge a stock's volatility is its "beta".

AGE.US volatility(beta: 1.45)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while AgeX Therapeutics's is 1.4498. This would suggest that AgeX Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Win £500 to get your trading started

Subscribe to trending stock alerts for a chance to win

By submitting, you agree to the Finder Privacy and Cookies Policy and Terms of Use

AgeX Therapeutics overview

AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes; and AGEX-VASC1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as the ischemic heart. Its lead drug-based therapeutic candidate in discovery is AGEX-iTR1547, a drug-based formulation to restore regenerative potential in a range of aged tissues afflicted with degenerative diseases. In addition, the company markets human embryonic stem cells; and GeneCards Database Suite, including genomic interpretation algorithms and analysis tools for use by researchers at pharmaceutical and biotechnology companies, and other institutions. AgeX Therapeutics, Inc. has a research collaboration with the University of California, Irvine on neural stem cell research program for Huntington's disease and other neurological disorders; and Sernova Corp. The company was founded in 2017 and is based in Alameda, California.

Frequently asked questions

More guides on Finder

  • How to buy Vroom shares | $27.97

    Learn more about Vroom’s recent performance and where you can invest in Vroom shares. We also run through some helpful rules of thumb for any investor.

  • How to buy Washington Prime shares | $1.87

    Learn more about Washington Prime Group’s recent performance and where you can invest in Washington Prime shares. We also run through some helpful rules of thumb for any investor.

  • How to buy Vertu Capital shares | 1.75p

    Learn more about Vertu Capital’s recent performance and where you can invest in Vertu Capital shares. We also run through some helpful rules of thumb for any investor.

  • How to buy ReTo Eco-Solutions shares | $1.66

    Learn more about ReTo Eco-Solutions’ recent performance and where you can invest in ReTo Eco-Solutions shares. We also run through some helpful rules of thumb for any investor.

  • How to buy RCI Hospitality Holdings shares

    Ever wondered how to buy shares in RCI Hospitality Holdings? We explain how and compare a range of providers that can give you access to many brands, including RCI Hospitality Holdings.

  • How to buy Norfolk Southern shares

    Ever wondered how to buy shares in Norfolk Southern? We explain how and compare a range of providers that can give you access to many brands, including Norfolk Southern.

  • How to buy ResMed shares

    Ever wondered how to buy shares in ResMed? We explain how and compare a range of providers that can give you access to many brands, including ResMed.

  • How to buy Motorola Solutions shares

    Ever wondered how to buy shares in Motorola Solutions? We explain how and compare a range of providers that can give you access to many brands, including Motorola Solutions.

  • How to buy Kinder Morgan shares

    Ever wondered how to buy shares in Kinder Morgan? We explain how and compare a range of providers that can give you access to many brands, including Kinder Morgan.

  • How to buy Enterprise Products Partners shares

    Ever wondered how to buy shares in Enterprise Products Partners? We explain how and compare a range of providers that can give you access to many brands, including Enterprise Products Partners.

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site